quinazolines has been researched along with sch 51866 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, HS; Chatterjee, M; Chintala, M; Chiu, P; Davis, H; Fawzi, A; Lin, CC; Sybertz, EJ; Tulshian, D; Vemulapalli, S; Watkins, RW | 1 |
1 other study(ies) available for quinazolines and sch 51866
Article | Year |
---|---|
Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Arteries; Blood Platelets; Cattle; Cell Division; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Enzyme Inhibitors; Humans; Hypertension; Imidazoles; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Platelet Aggregation Inhibitors; Quinazolines; Rats; Rats, Inbred SHR | 1996 |